Covid-19 accelerates the transformation of the healthcare sector and drives collaboration of pharmaceutical and medical devices manufacturers with other industries, particularly IT & digital. As Big Pharma executives concluded at one of their recent global virtual meetings, they are also working a lot closer together "racing against the virus, not against each other".
It is clear that this unprecedented crisis drove home the need to innovate and do it quickly. Collaboration across industries and across national borders and private/public sector boundaries is one clear method to accelerate innovation. Japan is one of leading players in this market and the government is taking increasing efforts to advance it.
What are the learning so far through the crisis on the effectiveness of collaboration in driving innovation? What are the best practice in teaming up with competitors and crossing private/public sector boundaries? How to create innovation ecosystems in healthcare and what is the particular situation in Japan?
Join us as we discuss the latest developments in the healthcare industry at our afternoon tea event on July 16 at 14:00-16:00.
Please note that this event is limited to senior-level executives and per invitation only. If you are not an existing member of The Economist Corporate Network, but would like to learn how you can attend our events, please contact us.